Laura Clague, Chief Financial Officer at Travere Therapeutics, Inc. (TVTX), sold 3,625 shares at $28.91 ($105K) on 2021-02-03, disclosed to the SEC on 2021-02-03.
Open-market sale of $105k TVTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.91 | 1,125 | $33K | 31.0% |
| 2 | $28.91 | 2,500 | $72K | 69.0% |
| Total | $28.91 avg | 3,625 | $105K | 100% |
| Filing → |
| TVTX | SELL | 2022-02-02 | $34K | — | Filing → |
| TVTX | SELL | 2022-01-26 | $103K | — | Filing → |
| TVTX | SELL | 2022-01-12 | $206K | — | Filing → |